• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, August 20, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by International Business Times referenced an article published in a supplement to The American Journal of Managed Care® (AJMC®), titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” In assessing the financial burden of Alzheimer disease, researchers said that unless new treatments or cures are developed, current treatment costs of $305 billion per year will rise to more than $1 trillion by 2050.

A piece by The Week spotlighted a video interview published on AJMC.com, the website of AJMC®. The interview, “Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine,” discussed false beliefs about COVID-19 vaccination, and why there is no good reason not to get inoculated, especially as the Delta variant spreads.

Related Videos
Leslie Fish, PharmD.
Ronesh Sinha, MD
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Pat Van Burkleo
Pat Van Burkleo
dr robert sidbury
Ben Jones, McKesson/Us Oncology
Kathy Oubre, MS, Pontchartrain Cancer Center
Jonathan E. Levitt, Esq, Frier Levitt, LLC
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.